Complication rates in leadless versus lead-based pacemaker therapy for sick sinus syndrome
E Von Felten, F Lugano, A Breitenstein, A Mueller, T Brix, C Wiederkehr, D Hofer · 2026
Read Complication rates in leadless versus lead-based pacemaker therapy for sick sinus syndrome by E Von Felten, F Lugano, A Breitenstein, A Mueller, T Brix, C Wiederkehr, D Hofer (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13300666.txt.
Description
E Von Felten and co-authors compare complication rates between atrial leadless pacemakers and conventional lead-based dual-chamber devices in sick sinus syndrome, in a 2026 retrospective study. Guidelines still favor the lead-based route, yet leads drive many complications and revisions. The single-center series covered fifty-two consecutive patients implanted between July 2024 and May 2025, seventeen receiving the new leadless atrial device and thirty-five the conventional system.
Procedures were far quicker with the leadless device, averaging twenty-seven minutes against seventy-two. Within ninety days, one leadless patient, about six percent, had a complication, against five lead-based patients at about fourteen percent. No leadless patient needed revision, while three lead-based patients did. None of these gaps reached statistical significance in so small a sample. The authors call the trend encouraging and ask for larger studies with longer follow-up to settle the comparison.
Catalog record
| CREATOR | E Von Felten, F Lugano, A Breitenstein, A Mueller, T Brix, C Wiederkehr, D Hofer |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |